What Determines Cross-Country Access to Antiretroviral Treatment?
| dc.contributor.author | Nattrass, Nicoli | |
| dc.date.accessioned | 2016-05-25T12:41:53Z | |
| dc.date.available | 2016-05-25T12:41:53Z | |
| dc.date.issued | 2006 | |
| dc.date.updated | 2016-05-25T12:41:00Z | |
| dc.description.abstract | Despite the recent international effort to expand access to highly active antiretroviral therapy (HAART) in developing countries, its coverage still varies significantly from country to country and is strongly correlated with per capita income. However, regional and political variables are also important. Cross-country regressions indicate that, controlling for political and economic characteristics and the scale of the HIV epidemic, Latin American and African countries have better coverage than predicted. Whereas the level of HIV prevalence was a significantly (negative) factor when accounting for HAART coverage in June 2004, this effect had disappeared by December 2004. The improvement appears to have benefited democratic countries in particular. | en_ZA |
| dc.identifier.apacitation | Nattrass, N. (2006). What Determines Cross-Country Access to Antiretroviral Treatment?. <i>Development Policy Review</i>, http://hdl.handle.net/11427/19852 | en_ZA |
| dc.identifier.chicagocitation | Nattrass, Nicoli "What Determines Cross-Country Access to Antiretroviral Treatment?." <i>Development Policy Review</i> (2006) http://hdl.handle.net/11427/19852 | en_ZA |
| dc.identifier.citation | Nattrass, N. (2006). What Determines Cross‐Country Access to Antiretroviral Treatment?. Development Policy Review, 24(3), 321-337. | en_ZA |
| dc.identifier.issn | 0950-6764 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Nattrass, Nicoli AB - Despite the recent international effort to expand access to highly active antiretroviral therapy (HAART) in developing countries, its coverage still varies significantly from country to country and is strongly correlated with per capita income. However, regional and political variables are also important. Cross-country regressions indicate that, controlling for political and economic characteristics and the scale of the HIV epidemic, Latin American and African countries have better coverage than predicted. Whereas the level of HIV prevalence was a significantly (negative) factor when accounting for HAART coverage in June 2004, this effect had disappeared by December 2004. The improvement appears to have benefited democratic countries in particular. DA - 2006 DB - OpenUCT DP - University of Cape Town J1 - Development Policy Review LK - https://open.uct.ac.za PB - University of Cape Town PY - 2006 SM - 0950-6764 T1 - What Determines Cross-Country Access to Antiretroviral Treatment? TI - What Determines Cross-Country Access to Antiretroviral Treatment? UR - http://hdl.handle.net/11427/19852 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/19852 | |
| dc.identifier.uri | http://onlinelibrary.wiley.com/doi/10.1111/j.1467-7679.2006.00327.x/abstract | |
| dc.identifier.vancouvercitation | Nattrass N. What Determines Cross-Country Access to Antiretroviral Treatment?. Development Policy Review. 2006; http://hdl.handle.net/11427/19852. | en_ZA |
| dc.language | eng | en_ZA |
| dc.publisher | Wiley | en_ZA |
| dc.publisher.department | Centre for Social Science Research(CSSR) | en_ZA |
| dc.publisher.faculty | Faculty of Humanities | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.source | Development Policy Review | en_ZA |
| dc.source.uri | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1467-7679/ | |
| dc.subject.other | Antiretroviral Treatment | |
| dc.title | What Determines Cross-Country Access to Antiretroviral Treatment? | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |